Avidity Partners Management LP
Position in TEVA — Teva Pharmaceutical Industries Ltd
CIK 1791827
DALLAS, TX
Position in TEVA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$6,776,000
+$752,000 QoQ
Shares Held
200,000
0.0% QoQ
Ownership
0.017%
of shares outstanding
% of Portfolio
1.09%
of 13F equity value
Holder Rank
#172
of 674 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TEVA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Avidity Partners Management LP holds $7,835,038 across 2 Drug Manufacturers - Specialty & Generic names. TEVA ranks #1 (86.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
This page
|
200,000 | $6,776,000 | |
| 2 | SCYX |
Scynexis Inc
|
260,206 | $1,059,038 |
All Filings in TEVA
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,776,000 | 200,000 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $6,024,000 | 200,000 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $13,023,933 | 417,300 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $10,302,000 | 510,000 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $11,556,020 | 689,500 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $7,392,970 | 481,000 | Shares | Sole | 2025-05-15 | |
| No filing history on record for this holder in this stock. | ||||||